Back to DEUTSCHE BANK AG\ DEUTSCHE BANK AG\

MNPRMNPR
5 quarters

Position history for DEUTSCHE BANK AG\DEUTSCHE BANK AG\'s holdings in MONOPAR THERAPEUTICS INC

DEUTSCHE BANK AG\ holds 31,008 shares of MNPR (MONOPAR THERAPEUTICS INC), worth $2.9M as of 2026-Q2. The position was increased (+7.6% shares). MNPR represents 0.0% of DEUTSCHE BANK AG\'s portfolio.

Current Value

$2.9M

Current Shares

31,008

Total Value Change

+$2.7M

Total Shares Change

+27,623

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
31,008
+7.6%
$2.9M0.0%$92.59
28
2026-Q1
Increased
28,822
+754.5%
$1.6M0.0%$51.88
41
2025-Q4
Decreased
3,373
-15.9%
$220,2570.0%$65.07
0
2025-Q3
Increased
4,012
+18.5%
$327,6600.0%$75.90
28
2025-Q2
New
3,385
-
$121,1150.0%$33.60
34

Other major holders of MNPR: Janus Henderson Group Ltd., RA CAPITAL MANAGEMENT, L.P., ADAGE CAPITAL PARTNERS GP, L.L.C.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used